Recognizing the Face of Cardiac Amyloidosis: Patient and Provider Perspectives Regarding Diagnosis, Treatment, and Symptom Management
This patient-centered curriculum will spotlight various aspects of the diagnosis, treatment, and long-term management of gaps in Transthyretin Amyloid Cardiomyopathy (ATTR-CM). Areas for discussion and review will include:
- Recognizing the changing epidemiology of ATTR;
- Awareness of at-risk and undiagnosed populations with transthyretin (TTR) amyloidosis to establish earlier diagnosis
- Distinguishing between subtypes in the modern era;
- Diagnostic methods: invasive and non-invasive;
- Clinical safety and efficacy data for new and emerging therapeutic agents;
- Acknowledging the quality of life and disease burden of patients with amyloidosis; and
- Incorporating supportive care strategies that reduce patient/provider burden along the pathway to diagnosis.
General Cardiologists, Heart Failure Nurses, Heart Failure Specialists, Neurologists, Echocardiographers, Nuclear Cardiologists, and Primary Care Physicians.
At the conclusion of this activity, participants will be able to (or better able to):
- Review the diagnostic criteria for amyloidosis and establish earlier diagnosis through guideline-based recommendations.
- Distinguish between hereditary and wild-type ATTR subtypes with regard to establishing diagnosis, treatments, and prognosis.
- Assess patients at elevated risk for ATTR amyloidosis in order to implement effective therapy that can help avoid cardiomyopathy.
- Review current and emerging therapeutic options for amyloidosis, with a focus on recent advances in therapeutics.
- Review nursing interventions for diseases management.
Eu sem integer vitae justo eget magna fermentum.
Vaishali Sanchorawala, MD
Activity Course Director
Professor of Medicine, Boston University School of Medicine
Director, Autologous Stem Cell Transplant Program
Director, Amyloidosis Center
Dr. Sanchorawala has disclosed that she is a consultant for Proclara, Regeneron, AbbVie, and Caelum. She has also received grant support from Celgene, Takeda, Janssen, Prothena, and Caelum.
Lisa M Mendelson, NP
Faculty Speaker and CNE Nurse Course Advisor
Hematology and Medical Oncology Provider
Assistant Professor of Medicine
Boston University School of Medicine
Ms. Mendelson has no financial relationships to disclose in relation to the content of this activity.
Frederick L Ruberg, MD
Director, Advanced Cardiovascular Imaging Program Associate
Director, Cardiovascular Fellowship Program
Associate Professor of Medicine and Radiology
Boston University School of Medicine
Dr. Ruberg receives grant support from Akcea Therapeutics, Alnylam Pharmaceuticals, Eidos and Pfizer Inc.
CME Project Manager: Michael Burk
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Boston University School of Medicine Continuing Nursing Education Provider Unit is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Contact Hours: 1.5, all of which are eligible for pharmacology credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive MOC points, you MUST pass the post-assessment and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through BUSM’s ACCME Program and Activity Reporting System (PARS). Please allow for 6-8 weeks for your MOC points to appear on your ABIM records.
ABIM/MOC: 1.5 Medical Knowledge MOC points
- 0.00 AAPA Category I CME
- 1.50 ABIM MOC II
- 0.00 ACPE Pharmacy
- 1.50 AMA PRA Category 1 Credit™Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 ANCCBoston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
- 1.50 Participation
Feugiat pretium nibh ipsum consequat nisl vel pretium lectus. Vehicula ipsum a arcu cursus vitae congue mauris rhoncus. Morbi leo urna molestie at elementum. Eget duis at tellus at. Molestie at elementum eu facilisis sed odio morbi quis. Egestas congue quisque egestas diam in arcu cursus euismod. Nunc scelerisque viverra mauris in aliquam sem fringilla ut. Sagittis nisl rhoncus mattis rhoncus urna neque. Viverra maecenas accumsan lacus vel. Purus in massa tempor nec feugiat nisl pretium fusce. Facilisi morbi tempus iaculis urna id. In vitae turpis massa sed elementum. Non tellus orci ac auctor augue mauris augue neque gravida. Diam sit amet nisl suscipit adipiscing bibendum est. Enim sit amet venenatis urna cursus. Velit ut tortor pretium viverra suspendisse potenti. Aliquam ultrices sagittis orci a scelerisque purus semper eget. Nisl purus in mollis nunc sed id. Turpis nunc eget lorem dolor sed viverra ipsum nunc.
Lobortis feugiat vivamus at augue. Id velit ut tortor pretium viverra suspendisse potenti nullam ac. Netus et malesuada fames ac turpis egestas integer eget. Augue ut lectus arcu bibendum at varius vel. Mattis molestie a iaculis at erat pellentesque adipiscing. Vitae semper quis lectus nulla at volutpat diam. Et malesuada fames ac turpis. Eu non diam phasellus vestibulum. Pellentesque elit ullamcorper dignissim cras tincidunt lobortis feugiat. Ligula ullamcorper malesuada proin libero nunc consequat interdum varius. Congue mauris rhoncus aenean vel. Imperdiet dui accumsan sit amet nulla facilisi morbi tempus iaculis. Ultrices vitae auctor eu augue. Egestas maecenas pharetra convallis posuere morbi leo. Faucibus et molestie ac feugiat sed lectus vestibulum. Viverra nam libero justo laoreet sit amet cursus sit. Justo donec enim diam vulputate ut pharetra sit amet.